Douglas S Krakower1,2, Susan E Beekmann3, Philip M Polgreen3,4, Kenneth H Mayer1,2. 1. Division of Infectious Diseases, Beth Israel Deaconess Medical Center. 2. The Fenway Institute, Fenway Health, Boston, Massachusetts. 3. Departments of Internal Medicine. 4. Epidemiology, University of Iowa Carver College of Medicine, Iowa City.
Abstract
BACKGROUND: US Public Health Service guidelines recommend early initiation of antiretroviral treatment (ART) for human immunodeficiency virus infection (HIV)-infected patients and preexposure prophylaxis (PrEP) as a prevention option for persons at risk for HIV acquisition. Before issuance of these guidelines, few clinicians reported prescribing early ART or PrEP. METHODS: The Emerging Infections Network, a national network of infectious diseases physicians in the United States and Canada, was surveyed in September 2014 to assess practices of adult HIV-care providers with early ART, PrEP, and other guideline-recommended HIV prevention methods. RESULTS: Almost half of the 1191 active members invited (48.1%) participated; 415 (72.4%) were HIV-care providers. Most providers (86.5%) indicated that they typically recommended ART initiation at diagnosis, irrespective of CD4(+) cell count. However, for patients with a CD4(+) cell count >500/µL, clinicians would defer ART if patients did not feel ready to initiate ART (94.7%) or had uncontrolled substance abuse (66.0%). Many providers had counseled HIV-infected patients about PrEP for partners (59.0%) or offered visits for partners to discuss PrEP (40.7%), and 31.8% had prescribed PrEP. Clinicians who deferred ART were less likely to endorse and engage in aspects of PrEP provision. CONCLUSIONS: Concordant with guidelines, most infectious diseases physicians recommend early ART, and many have experience with aspects of PrEP provision, suggesting recent evolution of clinician practices. Providers who defer ART are also cautious about PrEP. Interventions that help physicians motivate patients to initiate ART and identify missed opportunities to provide PrEP could enhance HIV prevention.
BACKGROUND: US Public Health Service guidelines recommend early initiation of antiretroviral treatment (ART) for human immunodeficiency virus infection (HIV)-infectedpatients and preexposure prophylaxis (PrEP) as a prevention option for persons at risk for HIV acquisition. Before issuance of these guidelines, few clinicians reported prescribing early ART or PrEP. METHODS: The Emerging Infections Network, a national network of infectious diseases physicians in the United States and Canada, was surveyed in September 2014 to assess practices of adult HIV-care providers with early ART, PrEP, and other guideline-recommended HIV prevention methods. RESULTS: Almost half of the 1191 active members invited (48.1%) participated; 415 (72.4%) were HIV-care providers. Most providers (86.5%) indicated that they typically recommended ART initiation at diagnosis, irrespective of CD4(+) cell count. However, for patients with a CD4(+) cell count >500/µL, clinicians would defer ART if patients did not feel ready to initiate ART (94.7%) or had uncontrolled substance abuse (66.0%). Many providers had counseled HIV-infectedpatients about PrEP for partners (59.0%) or offered visits for partners to discuss PrEP (40.7%), and 31.8% had prescribed PrEP. Clinicians who deferred ART were less likely to endorse and engage in aspects of PrEP provision. CONCLUSIONS: Concordant with guidelines, most infectious diseases physicians recommend early ART, and many have experience with aspects of PrEP provision, suggesting recent evolution of clinician practices. Providers who defer ART are also cautious about PrEP. Interventions that help physicians motivate patients to initiate ART and identify missed opportunities to provide PrEP could enhance HIV prevention.
Authors: Lisa R Metsch; Margaret Pereyra; Carlos del Rio; Lytt Gardner; Wayne A Duffus; Gordon Dickinson; Peter Kerndt; Pamela Anderson-Mahoney; Steffanie A Strathdee; Alan E Greenberg Journal: Am J Public Health Date: 2004-07 Impact factor: 9.308
Authors: Christina T Yuan; Ingrid M Nembhard; Amy F Stern; John E Brush; Harlan M Krumholz; Elizabeth H Bradley Journal: Issue Brief (Commonw Fund) Date: 2010-05
Authors: Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden Journal: N Engl J Med Date: 2010-11-23 Impact factor: 91.245
Authors: Gregory M Lucas; Amina Chaudhry; Jeffrey Hsu; Tanita Woodson; Bryan Lau; Yngvild Olsen; Jeanne C Keruly; David A Fiellin; Ruth Finkelstein; Patricia Barditch-Crovo; Katie Cook; Richard D Moore Journal: Ann Intern Med Date: 2010-06-01 Impact factor: 25.391
Authors: Chinazo O Cunningham; Hillary V Kunins; Robert J Roose; Rashiah T Elam; Nancy L Sohler Journal: J Gen Intern Med Date: 2007-07-10 Impact factor: 5.128
Authors: Mari M Kitahata; Stephen J Gange; Alison G Abraham; Barry Merriman; Michael S Saag; Amy C Justice; Robert S Hogg; Steven G Deeks; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; James J Goedert; Constance A Benson; Ann C Collier; Stephen E Van Rompaey; Heidi M Crane; Rosemary G McKaig; Bryan Lau; Aimee M Freeman; Richard D Moore Journal: N Engl J Med Date: 2009-04-01 Impact factor: 91.245
Authors: E Jennifer Edelman; Brent A Moore; Sarah K Calabrese; Gail Berkenblit; Chinazo Cunningham; Viraj Patel; Karran Phillips; Jeanette M Tetrault; Minesh Shah; David A Fiellin; Oni Blackstock Journal: AIDS Behav Date: 2017-04
Authors: John Weiser; John T Brooks; Jacek Skarbinski; Brady T West; Christopher C Duke; Garrett W Gremel; Linda Beer Journal: J Acquir Immune Defic Syndr Date: 2017-04-15 Impact factor: 3.731
Authors: Kate Buchacz; Jennifer Farrior; Geetha Beauchamp; Laura McKinstry; Ann E Kurth; Barry S Zingman; Fred M Gordin; Deborah Donnell; Kenneth H Mayer; Wafaa M El-Sadr; Bernard Branson Journal: J Int Assoc Provid AIDS Care Date: 2016-10-05
Authors: Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu Journal: AIDS Patient Care STDS Date: 2019-12 Impact factor: 5.078
Authors: Oni J Blackstock; Brent A Moore; Gail V Berkenblit; Sarah K Calabrese; Chinazo O Cunningham; David A Fiellin; Viraj V Patel; Karran A Phillips; Jeanette M Tetrault; Minesh Shah; E Jennifer Edelman Journal: J Gen Intern Med Date: 2016-10-24 Impact factor: 5.128
Authors: Sarah K Calabrese; Douglas S Krakower; Tiara C Willie; Trace S Kershaw; Kenneth H Mayer Journal: Clin Infect Dis Date: 2019-08-16 Impact factor: 9.079